Inactive Instrument

Medivolve Inc. Stock NEO Exchange

Equities

MEDV

CA58503M4083

Advanced Medical Equipment & Technology

Sales 2022 37.18 51.07 Sales 2023 0.69 0.94 Capitalization 390K 536K
Net income 2022 -18M -24.73M Net income 2023 -16M -21.98M EV / Sales 2022 22,108 x
Net cash position 2022 2.64M 3.63M Net Debt 2023 665K 913K EV / Sales 2023 1,537,011 x
P/E ratio 2022
-0.19 x
P/E ratio 2023
-0.02 x
Employees 25
Yield 2022 *
-
Yield 2023
-
Free-Float 94.14%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 21-04-29
Investor Relations Contact - -
More insiders
Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.
More about the company